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ABSTRACT Venezuelan and western equine encephalitis viruses (VEEV and WEEV, re-
spectively) invade the central nervous system (CNS) early during infection, via neuronal
and hematogenous routes. While viral replication mediates host shutoff, including ex-
pression of type I interferons (IFN), few studies have addressed how alphaviruses gain
access to the CNS during established infection or the mechanisms of viral crossing at
the blood-brain barrier (BBB). Here, we show that hematogenous dissemination of VEEV
and WEEV into the CNS occurs via caveolin-1 (Cav-1)-mediated transcytosis (Cav-MT)
across an intact BBB, which is impeded by IFN and inhibitors of RhoA GTPase. Use of re-
porter and nonreplicative strains also demonstrates that IFN signaling mediates viral re-
striction within cells comprising the neurovascular unit (NVU), differentially rendering
brain endothelial cells, pericytes, and astrocytes permissive to viral replication. Transmis-
sion and immunoelectron microscopy revealed early events in virus internalization and
Cav-1 association within brain endothelial cells. Cav-1-deficient mice exhibit diminished
CNS VEEV and WEEV titers during early infection, whereas viral burdens in peripheral tis-
sues remained unchanged. Our findings show that alphaviruses exploit Cav-MT to enter
the CNS and that IFN differentially restricts this process at the BBB.
IMPORTANCE VEEV, WEEV, and eastern equine encephalitis virus (EEEV) are emerging
infectious diseases in the Americas, and they have caused several major outbreaks in the
human and horse population during the past few decades. Shortly after infection, these
viruses can infect the CNS, resulting in severe long-term neurological deficits or death.
Neuroinvasion has been associated with virus entry into the CNS directly from the
bloodstream; however, the underlying molecular mechanisms have remained largely un-
known. Here, we demonstrate that following peripheral infection alphavirus augments
vesicular formation/trafficking at the BBB and utilizes Cav-MT to cross an intact BBB, a
process regulated by activators of Rho GTPases within brain endothelium. In vivo exami-
nation of early viral entry in Cav-1-deficient mice revealed significantly lower viral bur-
dens in the brain than in similarly infected wild-type animals. These studies identify a
potentially targetable pathway to limit neuroinvasion by alphaviruses.
KEYWORDS IFNAR, Venezuelan encephalitis virus, western equine encephalitis virus,
alphavirus, blood-brain barrier, caveola-mediated transcytosis, caveolin-1, in vivo
animal model, transcytosis assay, type I interferon
The central nervous system (CNS) is protected from pathogens by the blood-brainbarrier (BBB), an intercellular association of transmembrane junctional proteins
between brain microvascular endothelial cells (BMECs), with associated pericytes, as-
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trocytes, and neurons that together comprise the neurovascular unit (NVU) (1). Neu-
rotropic pathogens have evolved mechanisms to bypass or cross this barrier, including
anterograde or retrograde transport along axons, destabilization of BBB junctional
proteins, or passage through BMECs (2), the last of which may involve intracellular
transport within leukocytes via binding to intercellular adhesion molecule 1 (ICAM-1)
(3). An additional mechanism may involve caveolae, flask-shaped plasma membrane
invaginations within BMECs that are important for cell metabolism, signal transduction,
and the transcytosis of large proteins (4). BBB formation of caveolae, which contain the
major structural protein caveolin-1 (Cav-1), is limited by the major facilitator superfam-
ily domain-containing protein 2a (Mfsd2a), which is exclusively expressed on BMECs
and induced by pericytes (5). Stabilization of junctional proteins and caveolae within
BMECs is additionally regulated by the small Rho GTPases, including the Ras homolog
gene family, member A (RhoA), and Ras-related C3 botulinum toxin substrate 1 (Rac-1)
(6). While many viruses have evolved to interact with Rho GTPases to increase their
entry and replication within target cells (7, 8), some neurotropic viruses, including
retroviruses and flaviviruses, may compromise BBB permeability via GTPase-mediated
alterations of junctional proteins (9–12). For these viruses, neuroinvasion coincides with
BBB instability. In contrast, encephalitic alphaviruses, including Venezuelan, western,
and eastern equine encephalitis viruses (VEEV, WEEV, and EEEV, respectively), can enter
the CNS directly from the bloodstream via unknown mechanisms (13, 14).
VEEV, WEEV, and EEEV naturally cycle between mosquitoes and birds (EEEV and
WEEV), mosquitoes and rodents (VEEV enzootic cycle), or mosquitoes and horses (VEEV
epizootic cycle) and are all widely distributed in North, Central, and South America (15).
Human infection can progress rapidly to encephalitis with fatality rates of 1 to 75%,
depending on the strain. Of the three, VEEV is considered the most important zoonotic
pathogen, with several reported outbreaks in South and Central America, the latter of
which have spread to North America. Although the number of human cases reported
is small, the possibility for disease emergence is high due to expansion and spread of
mosquito vectors (16). Despite the epidemic potential of VEEV and the high morbidity
and/or case fatality rates of EEEV and WEEV, there are no approved vaccines or
therapeutics for humans. Insight into the cell-intrinsic and cell-extrinsic processes by
which the host limits alphavirus infections and minimizes virus- and immune-induced
injury is essential for developing strategies to contain virus dissemination and disease.
While early studies suggested that VEEV enters the CNS via anterograde transport along
peripheral nerves after cutaneous inoculation (17), recent findings, however, emphasize
that VEEV may cross the BBB via unknown mechanisms (13, 18).
In this study, we show that peripherally inoculated virulent strains of VEEV and WEEV
enter the CNS from the bloodstream as free virions through an intact BBB. While VEEV
and WEEV interact, enter, and traverse brain endothelium in vivo, virus replication
within brain microvascular endothelial cells (BMECs) and pericytes is inhibited by type
I interferon (IFN) signaling. Consistent with this, reporter and nonreplicative strains of
VEEV and WEEV were observed to first replicate within astrocytes and neurons, respec-
tively, suggesting that alphaviruses cross the BBB without replication in BMECs or
pericytes. Using an in vitro transcytosis assay, alphaviruses were found to utilize
caveolin-mediated transcytosis (Cav-MT), which is directly regulated by small Rho
GTPases and, notably, IFN. Transmission and immunoelectron microscopy revealed in
vivo virus encounter and entry at the BBB, with detection of VEEV within caveolin-1-
expressing BMECs. Importantly, deficiency in Cav-1 significantly delayed alphavirus
neuroinvasion during early infection, highlighting the important role of caveolae in CNS
entry. Together, these data suggest that IFNs regulate the CNS entry of encephalitic
alphaviruses via direct and indirect mechanisms.
RESULTS
Alphavirus neuroinvasion occurs prior to BBB disruption. To address mecha-
nisms of alphavirus neuroinvasion in susceptible hosts, we infected mice with enzootic
VEEV ZPC-738 (VEEV) and epizootic WEEV McMillan (WEEV) strains of alphaviruses (19,
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20). Wild-type mice infected with VEEV and WEEV via footpad (f.p.) inoculation exhib-
ited detectable virus replication simultaneously in both fore- and hindbrain regions at
1 and 3 days postinfection (dpi), respectively (Fig. 1A and B). Similar results were
observed in the brainstem and spinal cord (see Fig. S1A to D in the supplemental
material). Consistent with prior studies, the olfactory bulb exhibited higher VEEV titers
at early time points (17). Viral titers plateaued at 107 to 108 PFU/g of tissue by 3 to 4 dpi
(VEEV) and 4 to 5 dpi (WEEV). Significant alterations in BBB permeability occurred at
FIG 1 Alphavirus infection of the CNS occurs prior to BBB disruption. (A and B) Viral burdens in brain tissues of
C57BL/6 mice following f.p. infection with either VEEV (10 PFU) or WEEV (1,000 PFU), determined by plaque assay.
Dashed lines indicate the limit of detection of the assay. Viral burdens were measured at 1 dpi (VEEV) and 3 dpi
(WEE). (C and D) BBB permeability was determined at indicated dpi by measuring sodium fluorescein in CNS tissues
following intraperitoneal administration. Data are presented as mean viral titer or fluorescence  standard error
of the mean (SEM) for n  5 to 10 mice/group. *, P  0.05, **; P  0.01; ***, P  0.001, via 1-way analysis of variance
(ANOVA). (E) A schematic figure of an in vitro BBB model. AC, astrocyte. (F and G) Neither exposure of BMECs nor
exposure of ACs to VEEV and WEEV had any effects on barrier integrity. Addition of TNF- (100 ng/ml) significantly
reduced TEER over time. TEER values for each replicate are presented as normalized values, relative to their
respective TEER obtained at 0 h; absolute TEER values were in the 100-to-110 range ( · cm2). The experiment was
performed twice, each with 6 replicates. Error bars indicate mean  SEM. Statistically significant differences were
determined via 2-way ANOVA followed by Dunnett’s multiple-comparison test.
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plateau viral loads in both VEEV- and WEEV infected animals (Fig. 1C and D). Peak BBB
permeability in the brainstem and spinal cord also occurred at time points coinciding
with peak viral loads (Fig. S1C and D). We also examined direct effects of virus on BBB
integrity using an in vitro BBB model, in which primary murine BMECs are cultured on
transwell inserts over primary murine astrocytes in the bottom chamber (Fig. 1E). In this
model, barrier integrity is assessed by measuring transendothelial electrical resistance
(TEER) between the transwell chambers. While control cultures treated with tumor
necrosis factor alpha (TNF-) (100 ng/ml) displayed decreased TEER at all time points,
addition of virus to either BMECs or astrocytes had no effect on TEER (Fig. 1F and G).
To determine whether alphavirus infection of the CNS is associated with alterations in
tight junctions (TJ), we used an intranasal (i.n.) infection model in which VEEV is
administered into the nasal cavity of mice. In this model, VEEV utilizes retrograde
transport along olfactory sensory neurons and hematogenous routes of neuroinvasion
with similar kinetics of viral burdens and BBB permeability throughout the CNS as
observed after f.p. inoculation (Fig. S2A and B). Claudin-5 is the most predominant
claudin found in BBB TJ, with genetic deletion leading to uncontrolled BBB leakage and
perinatal death (21). Because claudin delocalization from TJ is sufficient to elicit TJ
permeability change independently of its total cellular abundance (22), we quantified
the claudin-5 protein abundance levels in BBB TJ from animals infected with VEEV via
direct visualization of claudin-5 protein within the TJ via immunogold labeling in
ultrathin electron microscopy (EM) sections. Consistent with the BBB permeability data,
established VEEV infection (6 dpi) significantly reduced the claudin-5 protein abun-
dance level within the endothelial TJ, while acute infection (from 12 h to 4 dpi) was
without significant effect (Fig. S2C and D). Together, our observations from in vivo and
in vitro experiments suggest that alphavirus neuroinvasion occurs in the presence of an
intact BBB.
Hematogenous route of neuroinvasion is not exclusive to the CVOs. Viral
neuroinvasion across an intact BBB could occur via virus replication within cellular
constituents of the NVU. To assess viral permissivity of NVU cells, we examined in vitro
alphavirus infection of isolated murine cells and performed multistep growth curve
analyses after infection with either VEEV (Fig. S3A to C) or WEEV (Fig. S3E to G). While
all cell types were permissive to both viruses, slopes of the curves differed; thus, virus
replication plateaued as early as 6 to 12 h postinfection (hpi) in astrocytes, while
pericytes and BMECs required 12 to 24 hpi and 24 to 48 hpi, respectively, to reach
plateau levels. To validate these findings in murine BMECs, the experiment was
performed using the human brain endothelial cell line hCMEC/D3, which displayed
similar results (Fig. S3D and H). These data suggest that differential restriction of
alphavirus replication may occur at the NVU. To examine this in vivo during early viral
neuroinvasion, we infected mice with 106 PFU of either VEEV-enhanced green fluores-
cent protein (eGFP) or WEEV-eGFP via intravenous (i.v.) injection, followed by immu-
nohistochemical (IHC) detection of GFP within brain tissues. Given the 2-day delay in
detection of WEEV compared with VEEV within the CNS (Fig. 1), CNS tissues of
VEEV-infected mice were examined at 16 hpi, while WEEV-infected mice were examined
at 48 hpi. Analyses of brains revealed multiple foci of viral replication throughout the
brain for both viruses, suggesting hematogenous routes of CNS entry. While some of
the entry sites overlapped with areas consistent with circumventricular organs (CVOs)
(Fig. 2A and B, arrows) (13), others were located within cortical and cerebellar areas that
are distant from these structures (Fig. 2A and B, arrowheads). In VEEV-infected mice,
GFP expression was detected in both NeuN neurons and S100- astrocytes (Fig. 2C).
In contrast, WEEV-infected animals exhibited GFP expression exclusively within neurons
(Fig. 2D). Notably, neither reporter strain led to early viral replication within BMECs or
pericytes (Fig. 2C and D), which is consistent with their diminished permissivity in vitro
compared with astrocytes. Together, these data suggest that cells of the NVU are
differentially susceptible to alphavirus infection in vivo and that, upon viremia, alpha-
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viruses invade the CNS from the bloodstream through multiple entry sites that are not
exclusive to CVOs.
IFNAR signaling differentially restricts alphavirus infection at the BBB. Given
our results demonstrating differential in vivo replication of alphaviruses within cells of
the NVU, we hypothesized that robust postentry restriction may be imposed by innate
immune responses within BMECs and pericytes. To address this, wild-type (WT) and
Ifnar/ mice were infected with VEEV-eGFP (100 PFU) via f.p. inoculation, and brain
tissues were examined at 1 dpi for GFP expression. Notably, Ifnar/ mice succumb to
VEEV-eGFP by 30 h postinfection (Fig. S4A), while WT animals have undetectable
brain infection using IHC at this time point (Fig. S4D). Thus, to allow comparisons at
similar viral burdens (Fig. S4C), we also evaluated brain tissues of WT mice at 3 dpi. VEEV
infection was limited to S100- astrocytes and NeuN neurons in WT animals (Fig. 3A
and Fig. S5A), whereas similar infection in Ifnar/ animals led to GFP expression within
BMECs and pericytes in both the cortex (Fig. 3B) and cerebellum (Fig. S5B). Next, we
assessed cellular tropism in the context of WEEV-eGFP (1,000 PFU) infection. Although
mortality was significantly increased in WEEV-eGFP-infected Ifnar/ mice compared
with similarly infected WT animals, Ifnar/ mice survive WEEV infection up to 5 to 6 dpi
(Fig. S4B), and viral infection was undetectable in brain tissues of either WT or Ifnar/
mice at 1 dpi (Fig. S4E). Thus, brain tissues were examined at 3 dpi for both genotypes.
Similarly to our observations with VEEV, WT mice infected with WEEV exhibited no GFP
expression in BMECs or pericytes, with infection detected only in neurons (Fig. 3C and
Fig. S5C). However, Ifnar/ mice additionally exhibited GFP expression within cortical
(Fig. 3D) and cerebellar (Fig. S5D) astrocytes.
As the observed changes in cellular tropism could be due to a higher titer of viremia
in Ifnar/ than in WT mice, Ifnar/ mice were infected with 106 PFU/ml of a
nonreplicative (NR) replicon derived from VEEV-eGFP (23), a physiologically relevant
dose that is equivalent to the level of viremia observed in WT mice after f.p. inoculation
(Fig. S5F). Following cellular entry, NR-VEEV-eGFP undergoes RNA replication and
produces reporter gene products, but no progeny virus, due to lack of structural genes
(23). Similarly to our results with WT VEEV-eGFP, WT animals infected with NR-VEEV-
eGFP had no infection of BEMCs or pericytes (Fig. 3E), whereas Ifnar/ mice exhibited
FIG 2 Hematogenous route of alphavirus neuroinvasion is not exclusive to CVOs. (A and B) Low magnification of a sagittal section
of VEEV-eGFP (A)- and WEEV-eGFP (B)-infected mouse brain showing multiple entry sites for CNS entry. Arrows indicate entry sites
consistent with CVOs. Arrowheads indicate entry sites distant from CVOs. (C and D) Brain tissues from VEEV-eGFP (C)- and WEEV-eGFP
(D)-infected mice were stained for markers of astrocytes (S100-, magenta, arrowhead), BMECs (CD31, red), pericytes (PDGFR-, red),
and neurons (NeuN, magenta, arrowhead). Insets are enlarged in lower left of each panel. Single channels relate to the enlarged insets.
Nuclei were counterstained with DAPI (blue). Magnification, 	40; bars, 20 m.
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extensive infection of these cell types in multiple brain regions, including the cortex
(Fig. 3F) and cerebellum (Fig. S5E). These findings support the notion that alphavirus
infection is differentially restricted at the NVU by IFNAR signaling, which prevents CNS
entry by blocking active virus replication within BMECs.
Ultrastructural analysis reveals alphavirus interaction and entry at the BBB. To
further characterize virus-cell interactions at the BBB in vivo, we performed transmission
electron microscopy (TEM) of CNS tissues derived from VEEV-infected WT and Ifnar/
mice. TEM analysis of Ifnar/ mice, which develop high level of viremia (Fig. S5F),
revealed 70-nm spherical structures with electron-dense cores, consistent with virions
(24), attached to the luminal surface of cortical microvessels (Fig. 4A). Additionally,
immunogold labeling using antibodies (Abs) against the VEEV E2 glycoproteins de-
tected viral particles inside cortical BMECs of WT mice (Fig. 4B). Since WT BMECs do not
support VEEV replication in vivo (Fig. 3A), detection of E2 glycoproteins likely represents
an intact virion rather than intracellular protein expression. Based on these observa-
tions, we hypothesized that VEEV may cross the BBB as free particles. To examine this,
mice were infected with NR-VEEV-eGFP via i.v. injection. At 1 dpi, we detected infection
FIG 3 Type I IFNs differentially restrict alphavirus replication within the NVU. (A to D) IHC staining of cortical brain regions of WT (A
and C) and Ifnar/ (B and D) mice following f.p. infection with either VEEV-eGFP (A and B) or WEEV-eGFP (C and D). Cell markers were
as follows: S100- for astrocytes, CD31 for BMECs, PDGFR- for pericytes, and NeuN for neurons. Nuclei were counterstained with DAPI
(blue). (E and F) IHC staining of cortical brain regions of WT (E) and Ifnar/ (F) mice following i.v. infection with NR-VEEV-eGFP.
Magnification, 	40; bars, 20 m.
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of astrocyte-like cells in multiple brain regions, including cortex and cerebellum (Fig. 4C
and D), suggesting that VEEV can cross the BBB as free virions, likely via a transcytosis
mechanism.
Alphavirus crosses brain endothelial cells via caveola-mediated transcytosis.
Based on our TEM data (Fig. 4A and B), we hypothesized that alphaviruses may exploit
BMEC endocytic machinery for entry across the BBB. In contrast to peripheral tissues,
the rate of transcytosis and numbers of endocytic vesicles are relatively low in BMECs
(5). However, exposure of BMECs to VEEV or WEEV (multiplicity of infection [MOI] of 10)
resulted in enhanced caveola formation at the cell surface (Fig. 5A to D). We next
quantified the number of caveola-like structures in BMECs of VEEV-infected mice.
Similar to our in vitro data, we observed increased vesiculation in cytoplasm and at the
luminal surface of BMECs in infected animals (Fig. 5E to G). In addition, virus infection
induced membrane ruffling in BMECs of infected mice (Fig. 5H). These observations
suggest a possible mechanism for viral transcytosis. To address this, we utilized a
transcytosis assay in which virus is added to the top chambers of transwell inserts for
60 min, followed by removal of inserts and assessment of infectious virions in the
bottom chamber (Fig. 6A). As the replication time of VEEV in BMECs is approximately
3 to 6 h (Fig. S6A), virus detected in the bottom chamber is unlikely due to replication,
which was confirmed via assessment of GFP expression in bottom chamber astrocytes
after transcytosis of NR-VEEV-eGFP virus (Fig. 6B). TEM evaluation of virus transcytosis
across BMECs additionally identified virion-like structures within endosomes, charac-
teristic of caveolae (25). Virion-containing endosomes were detected at various stages
of transcytosis, i.e., early endosomes, multivesicular bodies, and exocytic vesicles within
infected BMECs (Fig. 6C to E). Together, these data suggest that VEEV has the ability to
cross the endothelial cell barrier via a transcytosis mechanism.
Transcytosis may utilize various pathways, including macropinocytosis and clathrin-
or caveola-mediated endocytosis (CME or Cav-ME, respectively) (6, 26), which may be
interrogated via use of inhibitors including amiloride hydrochloride (macropinocytosis);
filipin, nystatin, and cholesterol oxidase (Cav-ME); and chlorpromazine (CME). Com-
FIG 4 Detection of alphavirus interaction and entry at the BBB. (A) TEM analysis of brain tissues from VEEV-infected mice at 1 dpi
identified virus-like particles attached to the luminal surface of microvessels. (B) Viral E2 glycoproteins were detected within cortical
BMECs of VEEV-eGFP-infected mice (3 dpi) by immuno-EM using 8-nm immunogold particles. Bars, 100 nm. (C and D) Immunostaining
of brain tissues collected from NR-VEEV-eGFP-infected WT mice at 1 day following i.v. infection. Cell markers were as follows: CD31 for
BMECs and NeuN for neurons. Nuclei were counterstained with DAPI (blue). Arrowheads indicate infected astrocyte-like cells.
Magnification, 	40; bars, 20 m.
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pared with untreated BMECs or hCMEC/D3, the percentage of transcytosis for both
VEEV and WEEV was significantly reduced in the presence of inhibitors of Cav-ME but
not CME or macropinocytosis (Fig. 6F to I). Notably, none of the inhibitors affected viral
infectivity or barrier integrity (Fig. S6B to E). In accordance with the key role of
caveolin-1 in caveola formation, Cav-1/ BMECs displayed diminished virus transcy-
FIG 5 Alphavirus infection enhances caveola formation in brain endothelial cells. (A to C) Exposure of BMECs to either VEEV or WEEV
at an MOI of 10 enhanced caveola formation at the cell surface compared to vehicle. (D) Quantitation of cell surface-associated
caveolae in BMECs after virus exposure. Statistical differences were analyzed by 1-way ANOVA followed by Dunnett’s multiple-
comparison test. ***, P  0.001. (E and F) TEM analysis of brain tissues collected from naive and VEEV-infected mice at 3 dpi. Black
arrowheads indicate luminal caveola-like structures. Orange arrowhead indicates intracellular vesicle. (G) Quantitation of caveola-like
structures at the cell surface and inside the cytoplasm of brain endothelial cells of naive versus infected animals. Three tissue blocks
were harvested from the cortical brain region of each mouse (n  3 in each group), and 30 images were obtained per block. After
manual counting, the mean vesicular density per length or volume of cytoplasm was calculated using ImageJ (NIH). Statistical
differences were analyzed using the t test. (H) TEM analysis demonstrating membrane ruffling (arrowhead) in BMECs of infected mice
relative to control animals.
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FIG 6 Alphavirus crosses BMECs via caveola-mediated transcytosis. (A) A schematic figure demonstrating different steps of a transcytosis
assay. (B) Addition of a nonreplicative strain of VEEV-eGFP to hCMEC/D3 on the top chamber resulted in GFP signals in human astrocytes
in the bottom chamber. (C to E) TEM analysis identified virus-like particles (depicted by arrows) within early endosomes (C), multivesicular
bodies (D) and exocytotic endosomes (E) in BMECs after exposure to VEEV for 30 min. (F to I) VEEV and WEEV traverse monolayers of BMECs
(F and H) and hCMEC/D3 (G and I) via caveola-mediated transcytosis. Data are presented as mean percentage of transcytosis relative to
untreated cells. Experiments were repeated 2 to 3 times each with 4 to 6 technical replicates. Error bars indicate standard errors of the
means (SEM). Concentrations of inhibitors are shown in parentheses: amiloride hydrochloride hydrate (50 M), cholesterol oxidase (CHOD;
2 U/ml), filipin (1 g/ml), nystatin (12 g/ml), and chlorpromazine (CPZ; 10 g/ml). (J) Quantitation of VEEV transcytosis across WT and
(Continued on next page)
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tosis compared to WT cells (Fig. 6J). These results were further verified using freeze
fracture electron microscopy, wherein we identified VEEV particles (8-nm gold particle;
orange arrow) colocalized with Cav-1 (16-nm gold particles, white arrow) (Fig. 6K). In
addition, lung endothelial cells exhibited significantly reduced virus transcytosis com-
pared to BMECs (Fig. 6L), suggesting specificity of alphavirus transcytosis for BMECs.
Caveola formation is enhanced by the small Rho GTPase RhoA, which is inhibited by
Rac1 activity (27, 28). Thus, we sought to evaluate virus transcytosis across BMECs in the
absence and presence of either Rho kinase inhibitor (H-1152, 50 nM and 100 nM) or
Rac-1 inhibitor (Z62954982, 100 M) (11, 29–32). While H-1152 significantly reduced
VEEV transcytosis across BMECs, Z62954982 had no significant effect on virus transmi-
gration (Fig. 6M). However, treatment with IFN- or IFN-, which has been shown to
promote BBB tight junction integrity via activation of Rac-1 (11), significantly reduced
VEEV transcytosis, suggesting direct effects of IFNAR signaling on Cav-MT (Fig. 6N).
Together, these results indicate that VEEV and WEEV exploit Cav-1-MT to cross an intact
BBB and that this may be regulated by IFN.
Caveolin-1 contributes to alphavirus neuroinvasion in vivo. To validate the role
of caveolin-1 in early alphavirus neuroinvasion in vivo, we infected WT and Cav-1/
mice with either VEEV (10 PFU) or WEEV (1000 PFU) via f.p. infection and examined
peripheral and CNS viral burdens at 1 and 3 dpi. As WEEV could not be detected in sera,
we examined splenic tissues. Both VEEV- and WEEV-infected Cav-1/ mice exhibited
significantly reduced viral titers in the cortex and cerebellum at 1 dpi and 3 dpi,
respectively, compared to similarly infected WT animals, whereas viral burdens in the
serum and spleen were indistinguishable between the two genotypes (Fig. 7A and B).
Importantly, no differences in CNS viral loads were detected in intracranial alphavirus-
infected WT compared with Cav-1/ mice (Fig. S7A and B), indicating no effect of
Cav-1 deficiency on viral replication within the CNS. These results indicate that while
Cav-MT is not the sole route of CNS entry by encephalitic alphaviruses, it significantly
contributes to viral seeding into the CNS following peripheral infection.
DISCUSSION
Using in vitro and in vivo approaches, we examined early events during alphavirus
neuroinvasion. We found that VEEV and WEEV can enter the CNS via hematogenous
dissemination across an intact BBB, without viral replication within BMECs or pericytes,
leading to productive infection of CNS-resident cells. Differential restriction of viral
infection within cellular constituents of the NVU is mediated by IFNAR signaling, with
FIG 6 Legend (Continued)
Cav-1/ BMECs. (K) Immunogold labeling of virally infected BMECs revealed VEEV (8-nm immunogold particles; orange arrow) in
colocalization with caveolin-1 (16-nm immunogold particles; white arrow). (L) VEEV transcytosis percentages were compared between
brain and lung ECs. (M and N) VEEV transcytosis across BMECs in the absence and presence of Rho kinase GTPase (H-1152P) and Rac-1
(Z62954982), as well as type I IFNs (100 pg/ml). Results from transcytosis assays were analyzed by 1-way ANOVA (F to I, M, and N) and t
test (J and L). *, P  0.05, **; P  0.01; ***, P  0.001.
FIG 7 Cav-1/ mice displayed reduced viral titers in the brain compared to WT animals. (A and B) Viral burdens in peripheral
and brain tissues of WT versus Cav-1 knockout mice after f.p. infection with VEEV (10 PFU) and WEEV (1,000 PFU), determined
by plaque assay. Error bars indicate standard errors of the means (SEM). Shown are the combined data from 4 independent
experiments each with 4 to 6 animals. Results were analyzed by unpaired t test: *, P  0.05; **, P  0.01.
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replication in BMECs and pericytes (VEEV) and astrocytes (WEEV) observed only in
Ifnar/ mice. VEEV and WEEV entry across the BBB occurs via Cav-MT, which is
impeded by Rho kinase inhibitor and IFN, the latter likely via activation of Rac1 (11, 12).
Immuno-EM demonstrated alphavirus interaction, internalization, and Cav-1 association
within BMECs both in vitro and in vivo. Consistent with this, Cav-1 deficiency reduced
alphavirus transcytosis in vitro and led to reduced titers of VEEV or WEEV in the CNS
during early infection in vivo. Taken together, these data suggest that innate immune
signaling regulates alphavirus neuroinvasion and replication at the NVU.
The CNS entry of alphaviruses following peripheral infection has been shown to
occur via multiple routes. Early studies in mice indicated that VEEV may reach the brain
via retrograde transport along peripheral nerves (17), whereas, more recently, VEEV and
other encephalitic alphaviruses have been shown to enter the CNS directly from the
bloodstream (13, 14, 33). In our study, peripheral infection of mice with virulent strains
of VEEV and WEEV resulted in detectable viral loads at time points that precede BBB
disruption (Fig. 1), and neither VEEV nor WEEV induced alterations in TEER across an in
vitro BBB. These results indicate that alphaviruses cross the BBB shortly after infection
without affecting barrier integrity. Hematogenous routes of neuroinvasion may include
viral passage through the CVOs, which lack specializations that comprise the BBB (13).
Our study demonstrated that shortly after i.v. infection (16 h), foci of alphavirus
infection are observed simultaneously in cortical and cerebellar locations distant from
the CVOs, suggesting that CNS entry is not exclusive to these structures. Notably, BBB
breakdown occurs at later time points, when viral loads have peaked. This is likely due
to induction of matrix metalloproteinase 9 (MMP-9) within CNS tissues that disrupts the
tight junction proteins between brain endothelial cells (18). Additionally, induction of
inflammatory immune responses (e.g., TNF and interleukin 6 [IL-6]) and upregulation of
cell adhesion molecules (e.g., ICAM-1 and vascular cell adhesion molecule 1 [VCAM-1])
on brain endothelium allows immune cell interaction and infiltration at the BBB, further
contributing to barrier disruption (18, 34, 35).
Pathogens, including viruses, may cross the BBB via direct infection of brain endo-
thelium (36, 37). Use of reporter and nonreplicative strains of VEEV and WEEV during in
vivo infection, however, indicated lack of infection within BMECs (Fig. 3), suggesting
that active virus replication in brain endothelium does not contribute to CNS entry.
VEEV has a broad tissue tropism and can infect many cell types, including macrophages
and dendritic cells (23). Infected leukocytes may act as Trojan horses and introduce viral
particles into the CNS upon infiltration. However, leukocyte interaction and extravasa-
tion at the BBB require elevated expression of cell adhesion molecules (CAMs) on brain
endothelium, which does not occur until 3 dpi (18). Since we detected significant viral
loads throughout the CNS by 1 dpi (Fig. 1), it is unlikely that infected leukocytes are the
initial source of virus in the CNS. Importantly, our data using NR-VEEV-eGFP did not
detect viral infection within CNS-infiltrating leukocytes, suggesting that virus can enter
CNS as free virions and independent of leukocyte trafficking. Nonetheless, additional
studies are required to precisely define the role of a Trojan horse in alphavirus
neuroinvasion.
Our TEM analysis demonstrated virus-like particles attached to the lumen of brain
endothelium. Given that viremia arises as early as 8 h after VEEV infection, BMECs are
likely among the first cell types exposed to virions. Such exposure may trigger innate
immune responses (e.g., type I IFNs), which can influence intercellular communication
at the NVU (38). Indeed, in the context of IFNAR deficiency, VEEV and WEEV replicate
within BMECs and astrocytes, respectively. The lack of viral replication within these
cellular constituents of the NVU in WT animals is likely due to paracrine effects of IFN
that induce antiviral proteins, as has been recently reported for arthritogenic alphavi-
ruses (39, 40). VEEV attachment to and internalization within BMECs were further
confirmed via immuno-TEM, in which viral E2 glycoproteins were detected within these
cells, supporting the notion that alphaviruses may cross the BBB via a transcytosis
pathway.
Compared to peripheral tissues, the rate of transcytosis at the BBB is unusually low.
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However, this rate may be augmented by increased Src kinase activity, which is
mediated by a group of pathological and nonpathological stimuli, including inflamma-
tory mediators and immune cell interactions with brain endothelium (41). Viruses may
also increase vesicular trafficking, as has been observed in peripherally derived endo-
thelial cells exposed to dengue virus (42). In our study, we utilized both in vitro assays
and in vivo viral infection models and observed that both VEEV and WEEV induce
formation of caveolae in BMECs. In vivo, VEEV-infected mice exhibited increased
vesiculation and membrane ruffling within brain endothelial cells (Fig. 5). In vitro
studies have shown that alphaviruses may induce dramatic structural changes in the
actin cytoskeleton, leading to the formation of filopodium-like extensions in infected
cells (43). Notably, expression of the viral nonstructural protein 1 (nsP1) alone is
sufficient to trigger formation of short extensions, which is dependent on its palmi-
toylation activity (44). Consistent with this, ablation of nsP1 palmitoylation sites abol-
ishes the ability of Semliki Forest virus (SFV) to infect the brain in murine models (45).
Elucidating molecular mechanisms underlying alphavirus-induced vesiculation in
BMECs may reveal therapeutic targets against viral neuroinvasion and provide insights
for BBB maintenance in the context of other neurological disorders induced by in-
creased transcytosis in brain endothelium (46–48).
Transcytosis of macromolecules across brain endothelium predominantly occurs via
mechanisms that utilize caveolae. During infectious diseases, interaction with caveolae
allows pathogens to escape lysosomal degradation and cross endothelial cell barriers (49,
50). While different families of viruses have been shown to cross epithelial and endothelial
cell barriers utilizing Cav-MT in vitro (51–53), in vivo findings to support these data have
been difficult to obtain, especially within the brain, where these events are rare. Our study
utilized multiple approaches to demonstrate that neurotropic alphaviruses enter but do not
replicate within brain endothelium and that Cav-MT contributes to in vivo viral infection of
the CNS. As peripherally infected Cav-1/ mice exhibit a delay in achievement of peak
brain titers of VEEV and WEEV compared to WT animals, entry of virus in the absence of
caveolae may rely on slower mechanisms of viral entry, such as retrograde transport along
axons (17). Additionally, recent studies have shown that encephalitic alphaviruses can gain
access to the CNS by viral passage through the CVOs, which lack the normal BBB (13).
Further, ablation of caveolin-1 results in upregulation of caveolin-independent pathways
(54), which might explain how viral loads within CNS tissues derived from Cav-1/ mice
quickly attain the levels observed in WT animals.
The signaling cascade underlying transcytosis was further elaborated using in vitro
assays, wherein deficiency in caveolin-1 or depletion of membrane cholesterol significantly
reduced VEEV and WEEV transcytosis across the BMEC monolayer. Notably, virus transcy-
tosis across brain endothelial cells was blocked by Rho kinase inhibitor (Fig. 6). The Rho
family of GTPases, including RhoA, Rac-1, and Cdc42, are known to play a role in pathogen
uptake and dissemination within the host (55–58). These proteins alternate between an
active GTP-bound form and an inactive GDP-bound form which triggers rearrangements in
the actin cytoskeleton and cellular uptake of pathogens (59). Studies in flavivirus enceph-
alitis have shown that IFN- acts in synergy with the Tyro3/Axl/Mer (TAM) receptor Mertk
to activate Rac-1, which enhances BBB tight junction integrity, thereby preventing para-
cellular entry of virus (11, 12). In the current study, we discovered that type I IFN also
prevents alphavirus transcytosis across BMECs. Thus, although the VEEV nsP2 and capsid
protein inhibit IFN signaling via host shutoff (60), the lack of viral replication within BMECs
may allow IFN signaling to limit viral entry likely via modulation of Rho GTPases (11).
In summary, mechanisms of encephalitic alphavirus neuroinvasion from the blood
are complex and may depend on individual viral tropism for olfactory sensory neurons
and cellular constituents of the NVU, which provide avenues of entry that cross the BBB,
respectively (23, 61). Neuroinvasion may also depend on innate immune mechanisms
that exert virus- and cell-specific effects on replication (60). Ablation of the olfactory
route reduces but does not eliminate CNS entry of VEEV (17), suggesting that each
route of entry provides a relative contribution to alphavirus neuroinvasion. Further
studies are needed to address how each process individually contributes to viral entry
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and whether viral spread within the CNS relies on these pathways or on innate immune
mechanisms that regulate intracellular viral trafficking and replication within permissive
cells. Our data highlighted the critical role of Cav-MT in alphavirus neuroinvasion.
Delineating molecular mechanisms involved in this process may reveal novel targets for
potential therapeutic interventions against CNS infection.
MATERIALS AND METHODS
Cells. Baby hamster kidney (BHK-21) and African green monkey kidney (Vero) cells were maintained
in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and
100 g/ml of penicillin and streptomycin. Primary murine brain microvascular endothelial cells (BMECs),
pericytes, and astrocytes were isolated from cortical brain of C57BL/6J mice and maintained in culture as
described previously (11, 62). The immortalized human cerebral microvascular endothelial cell line
hCMEC/D3 (63) was purchased from Millipore Sigma and maintained in endothelial cell growth basal
medium 2 (EBM2; Lonza). Primary human astrocytes and murine lung endothelial cells were purchased
from Sciencell Research Laboratories and Cell Biologics, respectively. Cells were maintained in the culture
medium recommended by each company.
Antibodies and reagents. Rabbit polyclonal anti-S100- (ab41548), rabbit monoclonal anticalbindin
(ab108404), and rabbit polyclonal anti-red fluorescent protein (anti-RFP) (ab62341) antibodies (Abs) were
purchased from Abcam Biotechnology. Purified rat anti-mouse CD31 (550274, clone MEC 13.3) and
guinea pig anti-NeuN (ABN90P) polyclonal Abs were purchased from BD Biosciences and Millipore-Sigma,
respectively. Goat anti-platelet-derived growth factor receptor beta (anti-PDGFR-) (AF1042) Ab was
purchased from R&D Systems. The anti-VEEV E2 monoclonal antibody was a kind gift from Michael
Diamond (Washington University, St. Louis, MO). Amiloride hydrochloride hydrate, filipin, cholesterol
oxidase, nystatin, chlorpromazine hydrochloride, Z62954982, and fluorescein sodium salt were pur-
chased from Sigma-Aldrich. (S)-Glycyl-H-1152 (hydrochloride) was purchased from the Cayman Chemical
Company. Mouse IFN- and - were obtained from PBL Assay Science.
Virus propagation, purification, and titration. All viruses used in this study, including the non-
replicative “replicon” strain of VEEV (NR-VEEV-eGFP), replication-competent VEEV, McMillan strain (WEEV),
and GFP reporter viruses (64), were generously provided by William Klimstra (University of Pittsburgh,
Pittsburgh, PA). The parental VEEV and WEEV cDNAs were gifts to Klimstra from Scott Weaver, University
of Texas Medical Branch at Galveston, and Kenneth Olson, Colorado State University, respectively. The
McMillan cDNA was modified by placing the entire virus coding region in a pBR322-based plasmid under
the control of a T7 bacteriophage promoter. Stocks of VEEV and WEEV viruses were generated as
described previously (34). Briefly, BHK-21 cells were infected at a multiplicity of infection (MOI) of 0.1.
Culture medium was replaced with fresh medium 4 h later. Virus-containing supernatants were collected
on the next day (30 h postinfection), cleared from cell debris by low-speed centrifugation, and filtered
through 0.22-m filters. Virus particles were then concentrated by ultracentrifugation at 100,000 	 g for
2 h at 4°C through a cushion of 30% (wt/wt) sucrose in phosphate-buffered saline (PBS). The virus pellet
was resuspended in PBS and stored in single-use aliquots at 80°C. Titrations of VEEV and WEEV were
performed in BHK-21 and Vero cells, respectively.
Multistep growth curves. Primary murine BMECs, astrocytes, and pericytes were seeded in 24-well
plates for 3 to 4 days until they reached confluence. At this point, cells were exposed to MOIs of 0.01, 0.1,
and 1 of VEEV and WEEV. Culture medium was removed 1 h postinfection, and cells were washed 4 times
with 1 ml/well of PBS. The last wash was stored at 80°C, and later it was used in a plaque assay to
determine residual unbound virus remaining in each well. Culture supernatant was harvested at specified
time points, and virus titer was determined using plaque assay in BHK-21 (VEEV) and Vero (WEEV) cells.
Mouse studies. C57BL/6J wild-type and caveolin-1-knockout mice were purchased from the Jackson
Laboratory (Bar Harbor, ME). Ifnar/ mice were kindly provided by Michael Diamond (Washington
University School of Medicine, St. Louis, MO). Animals were housed under pathogen-free conditions, and
the experimental procedures were completed in accordance with the Washington University School of
Medicine Animal Safety Committee. Male, 8- to 9-week-old mice were used in all in vivo experiments. Mouse
infections were performed by administering virus by either subcutaneous (s.c.), intravenous (i.v.), or intracra-
nial (i.c.) injection, while the mice were under light ketamine anesthesia. For subcutaneous infection, mice
were injected in the footpad with VEEV (10 PFU) and WEEV (1,000 PFU) in 50 l PBS. Intracranial infections
were performed by inoculating 10 PFU (VEEV) or 100 PFU (WEEV) of virus in 10 l of PBS into the right cerebral
hemisphere via a guided 29-gauge needle. Intravenous infections were achieved by administering 2 	 106
PFU of virus in 100 l of PBS via retro-orbital injection. Mock-infected animals received the same volume of
PBS in each infection method and were considered controls where needed.
Measurement of viral burden in tissues. To monitor the kinetics of virus spread in vivo, peripheral
organs and CNS tissues were harvested from infected mice at specified time points. Prior to this, mice
were perfused transcardially with 30 ml PBS. Tissues were homogenized in 500 l PBS using a MagNA
Lyser (6,000 rpm for 1 min) instrument, and virus titer in tissue homogenates was determined using
plaque assay in either BHK-21 or Vero cells depending on virus. Alternatively, groups of mice were
followed for survival assays.
In vivo assessment of BBB permeability. At given days postinfection, mice received 100 l of
100-mg/ml fluorescein sodium salt (NaFL) in PBS via intraperitoneal injection. When the salt reached
equilibrium (45 min), blood samples were collected, and mice were perfused transcardially with 30 ml
PBS prior to collection of CNS tissues. Serum samples and tissue homogenates were treated with 2%
trichloroacetic acid overnight at 4ºC to precipitate proteins. Supernatants were clarified from cellular
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debris by centrifugation (4,000 rpm for 20 min at 4°C) and diluted in equal volumes of borate buffer, pH
11 (Sigma-Aldrich). Concentration of NaFL in supernatants was determined by measuring fluorescence
emission at 538 nm using a Synergy H1 microplate reader (BioTek Instruments, Inc.). Measurement values
were normalized to tissue weight and to NaFL plasma concentration in each mouse.
In vitro BBB model and transcytosis assay. An in vitro BBB model was generated as described
elsewhere (34). Briefly, BMECs were seeded on the apical side of fibronectin-coated inserts (BD Falcon;
24-well, 3-m pores). Concurrently, primary murine astrocytes were cultured in fibronectin-coated 24-well
plates. Two days later, when astrocytes reached confluence, BMEC inserts were moved to an astrocyte-
containing plate. Astrocytes release growth factors that promote barrier formation between BMECs. Culture
medium was changed every 3 days. On day 7, hydrocortisone (550 nM), CTP-cAMP (250 M), and RO 20-1724
(17.5 M) compounds were added to the cells in serum-free medium to further promote expression of tight
junctions and barrier formation between BMECs. On the following day, barrier integrity was assessed by
measuring transendothelial electric resistance (TEER) before cells were used for transcytosis assay. In these
assays, BMECs on the top chamber are exposed to different treatments for 1 to 2 h. Virus particles are then
added at an MOI of 2 to BMECs on the top chamber for an additional hour. At this point, BMEC inserts are
removed and culture medium is collected from the bottom chamber and is used in plaque assay to determine
the number of virus particles that have crossed the BMEC monolayer in the presence and absence of different
inhibitors. Exposure of BMECs to alphavirus is limited to 1 h to prevent active virus replication and release of
viral progenies from the basolateral side.
Immunohistochemistry and confocal microscopy. Brain tissues were collected from infected mice
at specified time points as indicated in each figure legend. Prior to tissue collection, mice were deeply
anesthetized and perfused transcardially with 30 ml of PBS followed by 30 ml of 4% paraformaldehyde
(PFA). Tissues were stored overnight in 4% PFA in PBS at 4°C and then transferred into two exchanges
of 30% sucrose for 48 h, before they were embedded in O.C.T. compound (Tissue-Tek). Ten-micrometer
cryostat brain sections were treated with proteinase K (5 g/ml for 30 min at room temperature [RT]) for
antigen retrieval. After a 30-min incubation in blocking buffer, tissue sections were stained with primary
antibodies to markers for astrocytes (S100 calcium-binding protein [S100]-), pericytes (platelet-derived
growth factor receptor beta [PDGFR-]), BMECs (CD31), and neurons (NeuN and calbindin). Sections were
then incubated with appropriate secondary antibodies (Alexa Fluor 488 and 555 and DyLight 650, all
from Invitrogen) for 15 min in blocking buffer, followed by three washes in PBS. After antibody labeling,
cells were counterstained with 4=,6-diamidino-2-phenylindole (DAPI) (D1306; Invitrogen). All images were
obtained using a confocal microscope (Carl Zeiss) and processed with ImageJ software (NIH).
Transmission and immunogold electron microscopy. For TEM, mice underwent cardiac perfusion
with 5 ml of PBS, followed by 20 ml of 1.5% glutaraldehyde and 1% PFA in 0.12 M sodium pyrophosphate
buffer, while for immuno-EM studies, perfusion was performed with 5 ml of PBS and 20 ml of 4%
paraformaldehyde in 0.12 M sodium pyrophosphate buffer. Brain tissues were then collected and stored
in fixative buffer overnight at 4°C and processed as previously described (34). For immuno-EM, ultrathin
brain sections (70 nm) were stained with primary and gold-conjugated secondary antibodies on carbon-
coated glass. Sections were viewed on a JEM-1400 transmission microscope (JEOL) at 80 kV with an AMT
XR111 4k digital camera. For in vitro assays, a monolayer of BMECs on transwell inserts was infected with
alphavirus at an MOI of 200. After 30 min, culture medium was replaced with fixative buffer (2% PFA and
2.5% glutaraldehyde in 100 mM sodium cacodylate buffer, pH 7.2) and incubated for 1 h at room
temperature. Cells were then rinsed with sodium cacodylate buffer and embedded in a thin layer of 2.5%
agarose, followed by 1 h of fixation in 1% osmium tetroxide (Polysciences Inc.). After extensive washing
with distilled water (dH2O), cells were stained with 1% aqueous uranyl acetate (Ted Pella Inc., Redding,
CA) for 1 h, dehydrated through a series of ethanol concentrations in distilled water, and embedded in
Eponate 12 resin (Ted Pella Inc.). Ultrathin sections were generated at 95 nm using an UCT ultrami-
crotome (Leica Microsystems Inc., Bannockburn, IL) and stained with uranyl acetate and lead citrate.
Electron micrographs were obtained using a transmission electron microscope (JEOL 1200 EX; JEOL USA
Inc., Peabody, MA) equipped with an AMT 8-megapixel digital camera and AMT Image Capture Engine
V602 software (Advanced Microscopy Techniques, Woburn, MA).
Freeze fracture deep etching electron microscopy. Freeze fracture electron microscopy was
achieved as described previously (65). Briefly, cultured BMECs were rapidly frozen by abrupt application
of the sample against a liquid helium-cooled copper block with a Cryopress freezing machine. Samples
were then moved to a liquid nitrogen-cooled Balzers 400 vacuum evaporator, fractured, and etched at
104°C for 2.5 min. For immuno-freeze fracture EM, etched samples were first stained with primary and
gold-conjugated secondary antibodies on carbon-coated glass. These samples were then rotary repli-
cated with platinum (2 nm), deposited from a 20° angle above the horizontal plane, followed by an
immediate stabilization film of pure carbon (10 nm) deposited from an 85° angle. Replicas were floated
onto bleach and transferred through multiple rinses of dH2O before placing on Formvar-coated EM grids.
Electron micrographs were obtained using a JEM1400 transmission microscope (JEOL) at 80 kV, equipped
with an AMT XR111 4k digital camera.
Statistical analysis. Statistical analysis was performed using GraphPad Prism 7 software. A proba-
bility value of P  0.05 was considered statistically significant. Statistical values are indicated as follows:
*, P  0.05; **, P  0.01; ***, P  0.001.
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